Period tracker Clue collects 7 million euros – and also asks users to pay

The fem tech company founded in 2012 clue, best known for its period tracker app, today announced a €7 million funding round. The funds will be used to scale Clue’s digital family planning offering, expand the product portfolio and continue research to close the gender data gap.

The current round of funding is being led by existing investors Balderton Capital and Union Square Ventures. The new funding increases the total amount of venture capital that has flowed into Clue to approx 50 million euros.

The new funding is good news for Clue, after the company only announced in January that a quarter of its workforce to have to be fired.

For the first time in its history, Clue will also invite its community to via Crowdcube to become investors themselves. This step is intended to bring the most important stakeholders of the company, namely Clues users, even closer to the product development process. At the same time, investors have the opportunity to participate in the future success of the health tech company. You can take part from as little as ten euros.

As a community investor, you should be able to participate directly in the development of the Clue app and influence it directly through function surveys and tests as well as in forums.

According to Clue, eleven million people in 190 countries use the Clue app every month to better understand their own menstrual cycle and learn more about their reproductive health.

The basic period tracking features are free. If you want to know even more, you can book the premium subscription called “Clue Plus”, which offers users additional evidence-based functions and extended insights.

One of Clue’s premium features is Clue Conceive, a service intended to accompany users on their journey to conception. Twelve percent of paying Clue Plus users say they use this service.

Clue Plus costs EUR 9.99 per month, or EUR 39.99 once for an annual subscription.

In order to continue to grow, Clue intends to expand its product portfolio in the future to “include underserved stages of life, including menopause, and thus become a real companion app for life – from the first to the last period,” according to a press statement.

In addition, the Clue team intends to continue their research efforts to do their part to close the gender data gap.

Since its launch ten years ago, Clues users have logged over 530 million cycles. According to Clue, the anonymized data has already been incorporated into groundbreaking research work with research partners at universities such as Stanford and Oxford. For example, an investigation is currently underway into how the Covid-19 infection and vaccines affect the menstrual cycle.

“Despite making up half of the world’s population, the most common female health issues are still underidentified, understudied, and undertreated,” said Audrey Tsang, co-CEO of Clue.

“We created Clue because strengthening health starts with a better understanding of your own body. When you have the language and data to describe your experiences and stand up for yourself, it has a profound impact. The fact that it still takes an average of seven years to diagnose endometriosis is just one example of how much work still needs to be done in this area,” Tsang said.